Melanoma
Concept
Vocabulary Service
Overview
subject area of
-
A Cancer Vaccine Induces Expansion of NY-ESO-1-Specific Regulatory T Cells in Patients with Advanced Melanoma Academic Article
-
A Long, Naturally Presented Immunodominant Epitope from NY-ESO-1 Tumor Antigen: Implications for Cancer Vaccine Design Academic Article
-
A Novel HLA-B18 Restricted CD8+ T Cell Epitope Is Efficiently Cross-Presented by Dendritic Cells from Soluble Tumor Antigen Academic Article
-
A direct comparison of cytolytic T-lymphocyte responses to Melan-A peptides in vitro: differential immunogenicity of Melan-A27-35 and Melan-A26-35 Academic Article
-
A gene signature predicting natural killer cell infiltration and improved survival in melanoma patients Academic Article
-
A multisite blinded study for the detection of BRAF mutations in formalin-fixed, paraffin-embedded malignant melanoma Academic Article
-
A novel achiral seco-cyclopropylpyrido[e]indolone (CPyI) analog of CC-1065 and the duocarmycins: Synthesis, DNA interactions, in vivo anticancer and anti-parasitic evaluation Academic Article
-
A single-centre experience of patients with metastatic melanoma enrolled in a dabrafenib named patient programme Academic Article
-
ATP gradients inhibit the migratory capacity of specific human dendritic cell types: implications for P2Y11 receptor signaling Academic Article
-
Activation of anti-tumor cytotoxic T lymphocytes by fusion of human dendritic cells and melanoma cells Academic Article
-
Altered expression and splicing of ESRP1 in malignant melanoma correlates with epithelial- mesenchymal status and Tumor-Associated immune cytolytic activity Academic Article
-
An HLA-A2 polyepitope vaccine for melanoma immunotherapy Academic Article
-
An Open-Label, Two-Arm, Phase I Trial of Recombinant Human Interleukin-21 in Patients with Metastatic Melanoma Academic Article
-
Anti-programmed cell death protein 1 (anti-PD1) immunotherapy induced autoimmune polyendocrine syndrome type II (APS-2): A case report and review of the literature Academic Article
-
Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of Intralesional Bacillus Calmette-Guerin followed by Ipilimumab in Patients with Advanced Metastatic Melanoma Academic Article
-
B Cells and Antibody Production in Melanoma Academic Article
-
BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival Academic Article
-
BRAF V600 inhibition alters the microRNA cargo in the vesicular secretome of malignant melanoma cells Academic Article
-
BRAF/NRAS wild-type melanomas have a high mutation load correlating with histologic and molecular signatures of UV damage Academic Article
-
Bioinformatics pipelines for targeted resequencing and whole-exome sequencing of human and mouse genomes: a virtual appliance approach for instant deployment Academic Article
-
Blood Dendritic Cells Generated With Flt3 Ligand and CD40 Ligand Prime CD8+ T Cells Efficiently in Cancer Patients Academic Article
-
Brief report: Stem cell media culture of melanoma results in the induction of a nonrepresentative neural expression profile Academic Article
-
Cancer evolution during immunotherapy Academic Article
-
Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate Academic Article
-
Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells Academic Article
-
Capture and On-chip analysis of Melanoma Cells Using Tunable Surface Shear forces Academic Article
-
Cardiac metastases from malignant melanoma Academic Article
-
Cellular Mechanisms Underlying Complete Hematological Response of Chronic Myeloid Leukemia to BRAF and MEK1/2 Inhibition in a Patient with Concomitant Metastatic Melanoma Academic Article
-
Characterising the phenotypic evolution of circulating tumour cells during treatment Academic Article
-
Characteristics of pyrexia in BRAF V600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase I/II clinical trial Academic Article
-
Characterization of antigen-specific CD8+ T lymphocyte responses in skin and peripheral blood following intradermal peptide vaccination Academic Article
-
Clinical and Biological Efficacy of Recombinant Human Interleukin-21 in Patients with Stage IV Malignant Melanoma without Prior Treatment: A Phase IIa Trial Academic Article
-
Clinical and pathological associations of the activating RAC1 P29S mutation in primary cutaneous melanoma Academic Article
-
Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma Academic Article
-
Clinical promise of tumour immunology Academic Article
-
Clinical responses observed with imatinib or sorafenib in melanoma patients expressing mutations in KIT Academic Article
-
Clinicopathological characteristics associated with BRAF(K601E) and BRAF(L597) mutations in melanoma Academic Article
-
Clustered somatic mutations are frequent in transcription factor binding motifs within proximal promoter regions in melanoma and other cutaneous malignancies Academic Article
-
Combined BRAF (dabrafenib) and MEK inhibition (trametinib) in patients with BRAF V600 -mutant melanoma experiencing progression with single-agent BRAF inhibitor Academic Article
-
Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations Academic Article
-
Combining MHC tetramer and intracellular cytokine staining for CD8+ T cells to reveal antigenic epitopes naturally presented on tumor cells Academic Article
-
Concurrent Binding of Anti-EphA3 Antibody and Ephrin-A5 Amplifies EphA3 Signaling and Downstream Responses: Potential as EphA3-Specific Tumor-Targeting Reagents Academic Article
-
Delayed Autoimmune Toxicity Occurring Several Months After Cessation of Anti‐PD‐1 Therapy Case Study
-
Desmoplastic melanoma: comparison of expression of differentiation antigens and cancer testis antigens Academic Article
-
Determination of cell survival by RING-mediated regulation of inhibitor of apoptosis (IAP) protein abundance Academic Article
-
Development of a novel, quantitative protein microarray platform for the multiplexed serological analysis of autoantibodies to cancer-testis antigens Academic Article
-
Discovery of [18F]N-(2-(Diethylamino)ethyl)-6-fluoronicotinamide: A Melanoma Positron Emission Tomography Imaging Radiotracer with High Tumor to Body Contrast Ratio and Rapid Renal Clearance Academic Article
-
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade Academic Article
-
Distinct Clinical and Pathological Features Are Associated with the BRAFT1799A(V600E) Mutation in Primary Melanoma Academic Article
-
Distinctive subpopulations of stromal cells are present in human lymph nodes infiltrated with melanoma Academic Article
-
Early Growth Response Gene 1 (EGR1) Regulates Heparanase Gene Transcription in Tumor Cells Academic Article
-
Effect of thymidine analogs on tyrosinase activity and mRNA accumulation in mouse melanoma cells Academic Article
-
Effectiveness of dabrafenib in the treatment of patients with BRAF V600-mutated metastatic melanoma in a Named Patient Program Academic Article
-
Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy Academic Article
-
Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases Academic Article
-
Evolving role of tumor antigens for future melanoma therapies Academic Article
-
Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma Academic Article
-
FOXP3 is not mutated in human melanoma Academic Article
-
FOXP3 over-expression inhibits melanoma tumorigenesis via effects on proliferation and apoptosis. Academic Article
-
Fine-mapping naturally occurring NY-ESO-1 antibody epitopes in melanoma patients’ sera using short overlapping peptides and full-length recombinant protein Academic Article
-
First-in-Man Dose-Escalation Study of the Selective BRAF Inhibitor RG7256 in Patients with BRAF V600-Mutated Advanced Solid Tumors Academic Article
-
Fourier transform infrared imaging as a method for detection of HLA class I expression in melanoma without the use of antibody Academic Article
-
Frequent MAGE Mutations in Human Melanoma Academic Article
-
Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: differential regulation of function by specific classes of physiologic stimuli Academic Article
-
Genomic analysis of circulating tumor DNA using a melanoma-specific UltraSEEK oncogene panel Academic Article
-
Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients Academic Article
-
Heat Shock Protein Levels Are Not Elevated in Heat-Resistant B16 Melanoma Cells Academic Article
-
Hepatocyte growth factor renders BRAF mutant human melanoma cell lines resistant to PLX4032 by downregulating the pro-apoptotic BH3-only proteins PUMA and BIM Academic Article
-
High-Contrast PET of Melanoma Using 18F-MEL050, a Selective Probe for Melanin with Predominantly Renal Clearance Academic Article
-
Identifying and targeting determinants of melanoma cellular invasion Academic Article
-
Immune consequences of kinase inhibitors in development, undergoing clinical trials and in current use in melanoma treatment Academic Article
-
Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™ Academic Article
-
Immunohistochemical and Molecular Analysis of Human Melanomas for Expression of the Human Cancer-Testis Antigens NY-ESO-1 and LAGE-1 Academic Article
-
Immunological effects of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma Academic Article
-
Immunotherapy of advanced or metastatic melanoma Academic Article
-
Immunotherapy of melanoma: Targeting defined antigens Academic Article
-
Immunotherapy resistance: the answers lie ahead – not in front – of us Academic Article
-
Impact of 2-Deoxy-2[F-18]Fluoro-d-Glucose Positron Emission Tomography on the Management of Patients with Advanced Melanoma Academic Article
-
Improved Detection of Regional Melanoma Metastasis Using 18F-6-Fluoro-N-[2-(Diethylamino)Ethyl] Pyridine-3-Carboxamide, a Melanin-Specific PET Probe, by Perilesional Administration Academic Article
-
Intercellular Resistance to BRAF Inhibition Can Be Mediated by Extracellular Vesicle–Associated PDGFRβ1 Academic Article
-
Intratumoral genetic heterogeneity in metastatic melanoma is accompanied by variation in malignant behaviors Academic Article
-
Iterative sorting reveals CD133+and CD133-melanoma cells as phenotypically distinct populations Academic Article
-
Late presentation of generalised bullous pemphigoid-like reaction in a patient treated with pembrolizumab for metastatic melanoma Academic Article
-
Long-Term Outcomes in Patients With BRAF V600–Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib Academic Article
-
Loss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell lines Academic Article
-
Low-dose cyclophosphamide enhances antigen-specific CD4(+) T cell responses to NY-ESO-1/ISCOMATRIX (TM) vaccine in patients with advanced melanoma Academic Article
-
MAGE-12 and MAGE-6 are frequently expressed in malignant melanoma Academic Article
-
Melan-A–specific Cytotoxic T Cells Are Associated with Tumor Regression and Autoimmunity Following Treatment with Anti-CTLA-4 Academic Article
-
Melanoma vaccines: developments over the past 10 years Academic Article
-
Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations Academic Article
-
Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma Academic Article
-
Mutations in KIT occur at low frequency in melanomas arising from anatomical sites associated with chronic and intermittent sun exposure Academic Article
-
Mycoplasma Infection Alters Cancer Stem Cell Properties in Vitro Academic Article
-
NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus Academic Article
-
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma Academic Article
-
Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial Academic Article
-
Neutrophil to lymphocyte ratio is an independent predictor of outcome for patients undergoing definitive resection for stage IV melanoma Academic Article
-
Novel Imaging Techniques in Melanoma Academic Article
-
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy Academic Article
-
Optimizing combination dabrafenib and trametinib therapy in BRAF mutation-positive advanced melanoma patients: Guidelines from Australian melanoma medical oncologists Academic Article
-
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma Academic Article
-
Overall survival and durable responses in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib combined with trametinib Academic Article
-
PLX8394, a new generation BRAF inhibitor, selectively inhibits BRAF in colonic adenocarcinoma cells and prevents paradoxical MAPK pathway activation Academic Article
-
Patient-reported outcomes in KEYNOTE-006, a randomised study of pembrolizumab versus ipilimumab in patients with advanced melanoma Academic Article
-
Periarticular FDG uptake on PET/CT in malignant melanoma-metastatic or misleading? Case Study
-
Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma Academic Article
-
Predicting Clinical Outcome through Molecular Profiling in Stage III Melanoma Academic Article
-
Pregnancy associated plasma protein-A links pregnancy and melanoma progression by promoting cellular migration and invasion Academic Article
-
Radioimmunotherapy of fibroblast activation protein positive tumors by rapidly internalizing antibodies Academic Article
-
Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma Academic Article
-
Real-world efficacy and toxicity of combined nivolumab and ipilimumab in patients with metastatic melanoma Academic Article
-
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans Academic Article
-
Regioselective acylation of 3-O-angeloylingenol by Candida antarctica Lipase B Academic Article
-
Regulatory T-Cell–Mediated Attenuation of T-Cell Responses to the NY-ESO-1 ISCOMATRIX Vaccine in Patients with Advanced Malignant Melanoma Academic Article
-
Reply to ‘Comment on ‘Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy’’ Letter
-
Response to MAPK pathway inhibitors in BRAF V600M-mutated metastatic melanoma Academic Article
-
Restoring p53 Function in Human Melanoma Cells by Inhibiting MDM2 and Cyclin B1/CDK1-Phosphorylated Nuclear iASPP Academic Article
-
Role of nuclear medicine in the management of cutaneous malignant melanoma Academic Article
-
SCL gene in human tumors Academic Article
-
Season of diagnosis has no effect on survival from malignant melanoma Academic Article
-
Sentinel node biopsy for melanoma: The medical oncology perspective Letter
-
Small RNA deep sequencing discriminates subsets of extracellular vesicles released by melanoma cells - Evidence of unique microRNA cargos Academic Article
-
Spatially resolved analyses link genomic and immune diversity and reveal unfavorable neutrophil activation in melanoma Academic Article
-
Specific Targeting, Biodistribution, and Lack of Immunogenicity of Chimeric Anti-GD3 Monoclonal Antibody KM871 in Patients With Metastatic Melanoma: Results of a Phase I Trial Academic Article
-
Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-GD3 ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts Academic Article
-
Spontaneous T cell responses to melanoma differentiation antigens from melanoma patients and healthy subjects Academic Article
-
Standard of care in immunotherapy trials: challenges and considerations Academic Article
-
Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029) : an open-label, phase 1b trial Academic Article
-
Stroma remodeling and reduced cell division define durable response to PD-1 blockade in melanoma Academic Article
-
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade Academic Article
-
Synergism between membrane gangliosides and Arg-Gly-Asp-directed glycoprotein receptors in attachment to matrix proteins by melanoma cells. Academic Article
-
Synthesis and in Vivo Evaluation of [¹²³I]Melanin-Targeted Agents Academic Article
-
Systems analysis identifies miR-29b regulation of invasiveness in melanoma Academic Article
-
Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure Academic Article
-
The Ludwig Institute for Cancer Research Melbourne Melanoma Cell Line Panel Academic Article
-
The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression Academic Article
-
The Regulatory T Cell-Associated Transcription Factor FoxP3 Is Expressed by Tumor Cells Academic Article
-
The good, the (not so) bad and the ugly of immune homeostasis in melanoma Academic Article
-
The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand. Academic Article
-
The role of BRAF mutations in primary melanoma growth rate and survival Academic Article
-
The self peptide annexin II (208–223) presented by dendritic cells sensitizes autologous CD4+ T lymphocytes to recognize melanoma cells Academic Article
-
The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanoma Academic Article
-
The use of dendritic cells in cancer therapy Academic Article
-
Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma Academic Article
-
Tracking extracellular vesicle phenotypic changes enables treatment monitoring in melanoma Academic Article
-
Transketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cells Academic Article
-
Tumor Antigen Expression in Melanoma Varies According to Antigen and Stage Academic Article
-
Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery Academic Article
-
Tumor-Specific T-cell Help Is Associated with Improved Survival in Melanoma Editorial Article
-
Tumour procurement, DNA extraction, coverage analysis and optimisation of mutation-detection algorithms for human melanoma genomes Academic Article
-
Two phase I studies of low dose recombinant human IL-12 with Melan-A and influenza peptides in subjects with advanced malignant melanoma. Academic Article
-
Uncertain diagnosis and prognosis in advanced melanoma: a qualitative study of the experiences of bereaved carers in a time of immune and targeted therapies Academic Article
-
Use of [18F]-fluorodeoxyglucose positron emission tomography in monitoring response of recurrent neurotropic desmoplastic melanoma to radiotherapy Academic Article
-
Whole exome sequencing identifies a recurrent RQCD1 P131L mutation in cutaneous melanoma Academic Article
-
Whole-genome landscapes of major melanoma subtypes Academic Article